Dr. Ghosh joins the company from E-Scape Bio, where he served as chief scientific officer, heading discovery efforts for Alzheimer’s disease and neurodegenerative disorders. Previously he served as vice president, global head of Neuroscience Discovery and Biomarkers at Roche, where he led research and drug discovery for programs addressing neurodegenerative diseases as well as neurodevelopmental and psychiatric disorders.
“We are excited to have Anirvan Ghosh join us at Biogen,” said Dr. Ehlers. “After an extensive global search, we have found an inspired leader to guide an exceptional Research and Early Development team. Anirvan is an accomplished neuroscientist and industry R&D leader who has delivered multiple novel drug candidates to the clinic.”